New analysis from the Tufts Center for the Study of Drug Development (CSDD) and Palo Alto, CA-based Medable shows that AI ...

That's the broad idea behind Operation TRIALBLAZER, a campaign launched this summer by HHS and the FDA. On today's podcast, ...

LEO Pharma is betting up to $435 million on a pill that could give people with an ultra-rare light sensitivity disorder a way ...

Sanofi is laying off 229 former Blueprint Medicines employees in Cambridge, MA and closing two legacy Blueprint facilities.

A therapy room used to deliver the one-off, therapist-assisted treatment. Psychedelic drug developer Definium Therapeutics has reported positive phase 3 results with its LSD-based therapy, DT120, in ...

Blood disorder specialist Fulcrum Therapeutics has agreed to what amounts to a reverse merger with Slate Medicines, a ...

Novo Nordisk has joined forces with Amazon Web Services (AWS) on a project that will lead to the creation of an AI co-innovation hub in London, boosting the UK's standing as a hub for AI-powered drug ...

The pharma-adjacent tech and services sectors continued to attract experienced leadership talent during June and July, with ...

Lantheus Holdings, Inc., a Bedford, Massachusetts-headquartered radiopharmaceutical-focused company, announced on 14 th ...

DMD affects approximately 15,000 individuals in the United States and primarily impacts boys. Over time, deterioration of the ...

At this year’s NHS ConfedExpo, one message came through clearly: innovation is already improving care across the NHS, but we ...

Lund, Sweden-based Hansa Biopharma AB has announced that the first commercial patient in Australia has received a living donor kidney transplant following treatment with Idefirix (imlifidase), ...